SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (2010 - 2017)
Powered by 
Analysis
SELLAS Life Sciences (SLS) Property, Plant & Equipment (Net) (2010 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 107.22 Mn |
| 10 | SELLAS Life Sciences | 2.62 Bn | 2.62 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 123,000.00 |
| Jun 30, 2017 | 148,000.00 |
| Mar 31, 2017 | 173,000.00 |
| Dec 31, 2016 | 199,000.00 |
| Sep 30, 2016 | 226,000.00 |
| Jun 30, 2016 | 259,000.00 |
| Mar 31, 2016 | 299,000.00 |
| Dec 31, 2015 | 335,000.00 |
| Sep 30, 2015 | 288,000.00 |
| Jun 30, 2015 | 532,000.00 |
| Mar 31, 2015 | 528,000.00 |
| Dec 31, 2014 | 285,000.00 |
| Sep 30, 2014 | 589,000.00 |
| Jun 30, 2014 | 623,000.00 |
| Mar 31, 2014 | 653,000.00 |
| Dec 31, 2013 | 665,000.00 |
| Sep 30, 2013 | 545,000.00 |
| Jun 30, 2013 | 467,000.00 |
| Mar 31, 2013 | 27,000.00 |
| Dec 31, 2012 | 29,000.00 |